Lifetime Patient Management Greater Expectations: Is TAVI Rising to The Challenge?

Published: 24 March 2023

  • Views:

    Views Icon 2042
  • Likes:

    Heart Icon 7
  • episode_image
    Now Playing
    Part 1
    Welcome & Introduction
    David Hildick-Smith, Giuseppe Tarantini, Lars Søndergaard, Stefan Toggweiler
    Up Next
  • episode_image
    8m 42s
    Part 2 Live Case
    Stefan Toggweiler, David Hildick-Smith, Giuseppe Tarantini, Lars Søndergaard
  • episode_image
    4m 48s
    Part 6 Discussion & Close
    David Hildick-Smith, Giuseppe Tarantini, Lars Søndergaard, Stefan Toggweiler
Average (ratings)
No ratings
Your rating

Overview

This symposium, part of Transcatheter Interventions Online 2023, and chaired by Prof David Hildick-Smith (Brighton & Sussex University Hospitals NHS Trust, Brighton, UK), featured a panel discussion on the latest data on durability and clinical outcomes, an analysis of how TAVI is changing and possible future options for patients with aortic valve disease. The symposium also featured a minimalistic TAVI live case performed by Prof Stefan Toggweiler (Lucerne Cantonal Hospital, Lucerne, CH).

 

The live version of 'Lifetime Patient Management Greater Expectations: Is TAVI Rising to The Challenge?' was CME-accredited. This on-demand version is not.

 

This programme is supported by an unrestricted educational grant by Boston Scientific.

Learning Objectives:

  • Recall the latest data on durability and clinical outcomes for TAVI
  • Understand how TAVI is advancing and become aware of future treatment options for lifetime management of patients with aortic valve disease
  • Become more confident using TAVI in cases with complex anatomy

Target Audience

  • Interventional Cardiologists
  • Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
  • Interventional Cardiology Nurses

More from this programme

Part 1

Welcome & Introduction

Prof David Hildick-Smith introduces the symposium session and the panel.

Part 2

Live Case

In this video, Prof Stefan Toggweiler and his team at Lucerne Cantonal Hospital in Switzerland, introduce a minimalistic TAVI case. 

1 session
Live Case Watch now

Part 3

Data from 2022/23: What’s new in TAVI

Prof Giuseppe Tarantini presents what's new in TAVI, including data from 2022/23.

Part 4

Live Case

Prof Stefan Toggweiler shows the valve implantation procedure.

Part 5

How Is TAVI Advancing to Meeting Lifelong Management Goals

Prof Lars Søndergaard presents on how TAVI is advancing to meet lifelong management goals.

Part 6

Discussion & Close

Prof Hildick-Smith closes the symposium.

Faculty Biographies

David Hildick-Smith

David Hildick-Smith

Prof David Hildick-Smith is Professor of Interventional Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre - the Regional Specialist Unit. He is Director of the Cardiac Research, ex-Treasurer of the British Cardiovascular Interventions Society, and, with more than 20 years experience of Interventional Cardiology, is considered one of the country's leading experts in management of Cardiovascular complaints.

A pioneer of Interventional Cardiology, David is recognised internationally as a leader in cardiovascular diagnosis and treatment. 

View full profile
Giuseppe Tarantini

Giuseppe Tarantini

Prof Giuseppe Tarantini is the Head of the Interventional Cardiology Unit within the Department of Cardiac, Thoracic, and Vascular Sciences at the University of Padua Medical School, Padua, IT. He is a globally recognised researcher specialising in ischemic heart disease, structural heart disease, and cardiomyopathies.

Prof Tarantini serves as the primary operator for a diverse array of interventional procedures, encompassing coronary interventions (including atherectomies), peripheral interventions (such as carotid and renal procedures), and structural heart interventions (involving ASDs, PFOs, TAVI, and AVP).

In addition to his clinical work, Prof Tarantini is a distinguished faculty member at various international conferences, including Transcatheter Cardiovascular Therapeutics (TCT), the Congresso della Societa Italiana di Cardiologia Invasiva (SICI-GISE), Euro PCR, and the European Society of Cardiology (ESC). He boasts a publication record of 245 clinical…

View full profile
Lars Søndergaard

Lars Søndergaard

Professor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark. Professor of Cardiology at University of Copenhagen, he published over 300 peer reviewed articles, and more than 15 textbook chapters. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions, as well as congenital and structural heart diseases. He led the first-in-human transcatheter mitral valve implantation (CardiAQ) in 2012 and he actively participated to several trials, including NOTION (transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and low surgical risk), and the REDUCE randomised trial (PFO vs anti-platelet therapy after cryptogenic stroke).

View full profile
Stefan Toggweiler

Stefan Toggweiler

Stefan Toggweiler, PD Dr med, is the head of interventional valve therapy at Heart Center Lucerne.

View full profile

Comments

You must be to comment. If you are not registered, you can register here.
Elmukhtar Habas
1year
Nice demonisation